Detalhe da pesquisa
1.
Multiple myeloma cells' capacity to decompose H2O2 determines lenalidomide sensitivity.
Blood
; 129(8): 991-1007, 2017 02 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28028022
2.
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patients.
Ann Hematol
; 97(8): 1453-1462, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29623394
3.
Prevalence of BCL-2/J(H) Translocation in Healthy African Americans.
Ann Hematol
; 96(1): 51-55, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27730341
4.
Uncovering the biology of multiple myeloma among African Americans: a comprehensive genomics approach.
Blood
; 121(16): 3147-52, 2013 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23422747
5.
Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone.
Blood
; 118(16): 4359-62, 2011 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21860025
6.
Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03.
Br J Haematol
; 155(3): 340-8, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-21902684
7.
6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
Cancer Genet Cytogenet
; 169(2): 150-3, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16938573
8.
Biological and prognostic significance of interphase fluorescence in situ hybridization detection of chromosome 13 abnormalities (delta13) in multiple myeloma: an eastern cooperative oncology group study.
Cancer Res
; 62(3): 715-20, 2002 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11830525
9.
MYC dysregulation in the progression of multiple myeloma.
Leukemia
; 34(1): 322-326, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31439946
10.
Deletions of 17p13.1 and 13q14 are uncommon in Waldenström macroglobulinemia clonal cells and mostly seen at the time of disease progression.
Cancer Genet Cytogenet
; 132(1): 55-60, 2002 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-11801310
11.
Clinical implications of t(11;14)(q13;q32), t(4;14)(p16.3;q32), and -17p13 in myeloma patients treated with high-dose therapy.
Blood
; 106(8): 2837-40, 2005 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15976175
12.
A validated FISH trisomy index demonstrates the hyperdiploid and nonhyperdiploid dichotomy in MGUS.
Blood
; 106(6): 2156-61, 2005 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15920009
13.
Clinical and biologic implications of recurrent genomic aberrations in myeloma.
Blood
; 101(11): 4569-75, 2003 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12576322
14.
Waldenström macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions.
Blood
; 100(8): 2996-3001, 2002 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12351413
15.
Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients.
Blood
; 99(10): 3735-41, 2002 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-11986230